1. Home
  2. XYL vs VCYT Comparison

XYL vs VCYT Comparison

Compare XYL & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYL
  • VCYT
  • Stock Information
  • Founded
  • XYL 2011
  • VCYT 2006
  • Country
  • XYL United States
  • VCYT United States
  • Employees
  • XYL N/A
  • VCYT N/A
  • Industry
  • XYL Fluid Controls
  • VCYT Medical Specialities
  • Sector
  • XYL Industrials
  • VCYT Health Care
  • Exchange
  • XYL Nasdaq
  • VCYT Nasdaq
  • Market Cap
  • XYL 31.5B
  • VCYT 2.1B
  • IPO Year
  • XYL N/A
  • VCYT 2013
  • Fundamental
  • Price
  • XYL $132.71
  • VCYT $23.34
  • Analyst Decision
  • XYL Buy
  • VCYT Buy
  • Analyst Count
  • XYL 8
  • VCYT 9
  • Target Price
  • XYL $146.29
  • VCYT $39.89
  • AVG Volume (30 Days)
  • XYL 1.3M
  • VCYT 1.0M
  • Earning Date
  • XYL 07-31-2025
  • VCYT 08-06-2025
  • Dividend Yield
  • XYL 1.21%
  • VCYT N/A
  • EPS Growth
  • XYL 30.51
  • VCYT N/A
  • EPS
  • XYL 3.71
  • VCYT 0.41
  • Revenue
  • XYL $8,598,000,000.00
  • VCYT $463,393,000.00
  • Revenue This Year
  • XYL $3.25
  • VCYT $12.55
  • Revenue Next Year
  • XYL $4.81
  • VCYT $9.79
  • P/E Ratio
  • XYL $35.66
  • VCYT $56.63
  • Revenue Growth
  • XYL 8.16
  • VCYT 23.42
  • 52 Week Low
  • XYL $100.48
  • VCYT $19.73
  • 52 Week High
  • XYL $143.50
  • VCYT $47.32
  • Technical
  • Relative Strength Index (RSI)
  • XYL 64.00
  • VCYT 29.95
  • Support Level
  • XYL $128.51
  • VCYT $26.18
  • Resistance Level
  • XYL $132.47
  • VCYT $27.91
  • Average True Range (ATR)
  • XYL 1.85
  • VCYT 0.96
  • MACD
  • XYL -0.02
  • VCYT -0.26
  • Stochastic Oscillator
  • XYL 95.36
  • VCYT 0.00

About XYL Xylem Inc. New

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Share on Social Networks: